|
1
|
Inglehart RC, Scanlon CS and D'Silva NJ:
Reviewing and reconsidering invasion assays in head and neck
cancer. Oral Oncol. 50:1137–1143. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Machiels JP, Lambrecht M, Hanin FX, Duprez
T, Gregoire V, Schmitz S and Hamoir M: Advances in the management
of squamous cell carcinoma of the head and neck. F1000Prime Rep.
6:442014. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kaba G, Dzudzor B, Gyasi RK, Asmah RH,
Brown CA, Kudzi W and Wiredu EK: Human papillomavirus genotypes in
a subset of head and neck squamous cell carcinoma. West Afr J Med.
33:121–124. 2014.PubMed/NCBI
|
|
4
|
Woods R Sr, O'Regan EM, Kennedy S, Martin
C, O'Leary JJ and Timon C: Role of human papillomavirus in
oropharyngeal squamous cell carcinoma: A review. World J Clin
Cases. 2:172–193. 2014.PubMed/NCBI
|
|
5
|
Dang M, Lysack JT, Wu T, Matthews TW,
Chandarana SP, Brockton NT, Bose P, Bansal G, Cheng H, Mitchell JR,
et al: MRI texture analysis predicts p53 status in head and neck
squamous cell carcinoma. AJNR Am J Neuroradiol. 36:166–170. 2015.
View Article : Google Scholar
|
|
6
|
Maruyama H, Yasui T, Ishikawa-Fujiwara T,
Morii E, Yamamoto Y, Yoshii T, Takenaka Y, Nakahara S, Todo T,
Hongyo T, et al: Human papillomavirus and p53 mutations in head and
neck squamous cell carcinoma among Japanese population. Cancer Sci.
105:409–417. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shi Q, Xiao K, Wei W, Zhang BY, Chen C, Xu
Y, Chen LN, Song YT, Ma X, Zhang NS, et al: Associations of TP53
mutations, codon 72 polymorphism and human papillomavirus in head
and neck squamous cell carcinoma patients. Oncol Rep. 30:2811–2819.
2013.PubMed/NCBI
|
|
8
|
Colby DW and Prusiner SB: Prions. Cold
Spring Harb Perspect Biol. 3:a0068332011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liberski PP: Historical overview of prion
diseases: A view from afar. Folia Neuropathol. 50:1–12.
2012.PubMed/NCBI
|
|
10
|
Gasperini L and Legname G: Prion protein
and aging. Front Cell Dev Biol. 2:442014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Llorens F, Ferrer I and del Río JA: Gene
expression resulting from PrPC ablation and
PrPC overexpression in murine and cellular models. Mol
Neurobiol. 49:413–423. 2014. View Article : Google Scholar
|
|
12
|
Yusa S, Oliveira-Martins JB,
Sugita-Konishi Y and Kikuchi Y: Cellular prion protein: From
physiology to pathology. Viruses. 4:3109–3131. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He M, Wang L, Pu J, Yang Q, Li G and Hao
J: Proliferin-related protein overexpression in SGC-7901 gastric
cancer cells inhibits in vitro cell growth and tumorigenesis in
nude mice. Oncol Rep. 29:2243–2248. 2013.PubMed/NCBI
|
|
14
|
Sy MS, Altekruse SF, Li C, Lynch CF,
Goodman MT, Hernandez BY, Zhou L, Saber MS, Hewitt SM and Xin W:
Association of prion protein expression with pancreatic
adenocarcinoma survival in the SEER residual tissue repository.
Cancer Biomark. 10:251–258. 2011–2012.
|
|
15
|
Farah J, Sayah R, Martinetti F, Donadille
L, Lacoste V, Hérault J, Delacroix S, Nauraye C, Vabre I, Lee C, et
al: Secondary neutron doses in proton therapy treatments of ocular
melanoma and craniopharyngioma. Radiat Prot Dosimetry. 161:363–367.
2014. View Article : Google Scholar
|
|
16
|
Antony H, Wiegmans AP, Wei MQ, Chernoff
YO, Khanna KK and Munn AL: Potential roles for prions and
protein-only inheritance in cancer. Cancer Metastasis Rev. 31:1–19.
2012. View Article : Google Scholar :
|
|
17
|
Hinton C, Antony H, Hashimi SM, Munn A and
Wei MQ: Significance of prion and prion-like proteins in cancer
development, progression and multi-drug resistance. Curr Cancer
Drug Targets. 13:895–904. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wei W, Shi Q, Guo F, Zhang BY, Chen C,
Zhang NS and Dong XP: The distribution of human papillomavirus in
tissues from patients with head and neck squamous cell carcinoma.
Oncol Rep. 28:1750–1756. 2012.PubMed/NCBI
|
|
19
|
Gao JM, Gao C, Han J, Zhou XB, Xiao XL,
Zhang J, Chen L, Zhang BY, Hong T and Dong XP: Dynamic analyses of
PrP and PrPSc in brain tissues of golden hamsters
infected with scrapie strain 263K revealed various PrP forms.
Biomed environ Sci. 17:8–20. 2004.PubMed/NCBI
|
|
20
|
Zhang J, Chen L, Zhang BY, Han J, Xiao XL,
Tian HY, Li BL, Gao C, Gao JM, Zhou XB, et al: Comparison study on
clinical and neuropathological characteristics of hamsters
inoculated with scrapie strain 263K in different challenging
pathways. Biomed Environ Sci. 17:65–78. 2004.PubMed/NCBI
|
|
21
|
Antonacopoulou AG, Palli M, Marousi S,
Dimitrakopoulos FI, Kyriakopoulou U, Tsamandas AC, Scopa CD,
Papavassiliou AG and Kalofonos HP: Prion protein expression and the
M129V polymorphism of the PRNP gene in patients with colorectal
cancer. Mol Carcinog. 49:693–699. 2010.PubMed/NCBI
|
|
22
|
Duhayon S, Hoet P, Van Maele-Fabry G and
Lison D: Carcinogenic potential of formaldehyde in occupational
settings: A critical assessment and possible impact on occupational
exposure levels. Int Arch Occup Environ Health. 81:695–710. 2008.
View Article : Google Scholar
|
|
23
|
Pan Y, Zhao L, Liang J, Liu J, Shi Y, Liu
N, Zhang G, Jin H, Gao J, Xie H, et al: Cellular prion protein
promotes invasion and metastasis of gastric cancer. FASEB J.
20:1886–1888. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meslin F, Conforti R, Mazouni C, Morel N,
Tomasic G, Drusch F, Yacoub M, Sabourin JC, Grassi J, Delaloge S,
et al: Efficacy of adjuvant chemotherapy according to Prion protein
expression in patients with estrogen receptor-negative breast
cancer. Ann Oncol. 18:1793–1798. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liang J, Pan YL, Ning XX, Sun LJ, Lan M,
Hong L, Du JP, Liu N, Liu CJ, Qiao TD, et al: Overexpression of
PrPC and its antiapoptosis function in gastric cancer.
Tumour Biol. 27:84–91. 2006. View Article : Google Scholar
|
|
26
|
Li C, Yu S, Nakamura F, Yin S, Xu J,
Petrolla AA, Singh N, Tartakoff A, Abbott DW, Xin W, et al: Binding
of pro-prion to filamin A disrupts cytoskeleton and correlates with
poor prognosis in pancreatic cancer. J Clin Invest. 119:2725–2736.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sy MS, Li C, Yu S and Xin W: The fatal
attraction between pro-prion and filamin A: Prion as a marker in
human cancers. Biomarkers Med. 4:453–464. 2010. View Article : Google Scholar
|
|
28
|
Sauer H, Dagdanova A, Hescheler J and
Wartenberg M: Redox-regulation of intrinsic prion expression in
multicellular prostate tumor spheroids. Free Radic Biol Med.
27:1276–1283. 1999. View Article : Google Scholar
|
|
29
|
Zhang J, Zeng Y, Zheng J and Xu J:
Expression of Prion protein and its clinical significance in oral
squamous cells carcinoma and oral leukoplakia. Zhonghua Kou Qiang
Yi Xue Za Zhi. 48:752–754. 2013.In Chinese.
|
|
30
|
Wang JH, Du JP, Zhang YH, Zhao XJ, Fan RY,
Wang ZH, Wu ZT and Han Y: Dynamic changes and surveillance function
of prion protein expression in gastric cancer drug resistance.
World J Gastroenterol. 17:3986–3993. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Courtney R and Ranganathan S: Simultaneous
adrenocortical carcinoma and neuroblastoma in an infant with a
novel germline p53 mutation. J Pediatr Hematol Oncol. 37:215–218.
2015. View Article : Google Scholar
|
|
32
|
Seema R, Parul S, Nita K and Kamlesh:
High-risk histomorphological features in retinoblastoma and their
association with p53 expression: An Indian experience. Indian J
Ophthalmol. 62:1069–1071. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li ZD, Wang K, Yang XW, Zhuang ZG, Wang JJ
and Tong XW: Expression of aryl hydrocarbon receptor in relation to
p53 status and clinicopathological parameters in breast cancer. Int
J Clin Exp Pathol. 7:7931–7937. 2014.
|
|
34
|
Read ML, Seed RI, Modasia B, Kwan PP,
Sharma N, Smith VE, Watkins RJ, Bansal S, Gagliano T, Stratford AL,
et al: The proto-oncogene PBF binds p53 and is associated with
prognostic features in colorectal cancer. Mol Carcinog. Nov
18–2014.Epub ahead of print. PubMed/NCBI
|
|
35
|
Silva JL, De Moura Gallo CV, Costa DC and
Rangel LP: Prion-like aggregation of mutant p53 in cancer. Trends
Biochem Sci. 39:260–267. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Al-Qasem A, Toulimat M, Tulbah A, Elkum N,
Al-Tweigeri T and Aboussekhra A: The p53 codon 72 polymorphism is
associated with risk and early onset of breast cancer among Saudi
women. Oncol Lett. 3:875–878. 2012.PubMed/NCBI
|
|
37
|
Zaravinos A: An updated overview of
HPV-associated head and neck carcinomas. Oncotarget. 5:3956–3969.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Petit CS, Besnier L, Morel E, Rousset M
and Thenet S: Roles of the cellular prion protein in the regulation
of cell-cell junctions and barrier function. Tissue Barriers.
1:e243772013. View Article : Google Scholar
|
|
39
|
Roucou X: Regulation of PrPC
signaling and processing by dimerization. Front Cell Dev Biol.
2:572014. View Article : Google Scholar
|
|
40
|
Martin-Lannerée S, Hirsch TZ,
Hernandez-Rapp J, Halliez S, Vilotte JL, Launay JM and
Mouillet-Richard S: PrPC from stem cells to cancer.
Front Cell Dev Biol. 2:552014.
|
|
41
|
Cheng Y, Li Y, Liu D, Zhang R and Zhang J:
miR-137 effects on gastric carcinogenesis are mediated by targeting
Cox-2-activated PI3K/AKT signaling pathway. FEBS Lett.
588:3274–3281. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xue P, Yang X, Liu Y, Xiong C and Ruan J:
A novel compound RY10-4 downregulates P-glycoprotein expression and
reverses multidrug-resistant phenotype in human breast cancer
MCF-7/ADR cells. Biomed Pharmacother. 68:1049–1056. 2014.
View Article : Google Scholar : PubMed/NCBI
|
